gemcitabine has been researched along with 1-palmitoyl-2-oleoylphosphatidylcholine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambre, AH; Borowicz, PP; Guo, B; Haldar, MK; Katti, KS; Katti, P; Kulkarni, PS; Mallik, S; Muhonen, WW; Nahire, RR; Padi, SK; Reindl, K; Shabb, JB; Shrivastava, DK; Singh, RK | 1 |
1 other study(ies) available for gemcitabine and 1-palmitoyl-2-oleoylphosphatidylcholine
Article | Year |
---|---|
Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Extracellular Matrix; Female; Gemcitabine; Glutathione; Humans; Hydrolysis; Lipid Bilayers; Lipopeptides; Matrix Metalloproteinase 9; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Transport Vesicles | 2014 |